First cardiovascular-kidney-metabolic disease

There are 2 papers on first cardiovascular-kidney-metabolic disease in aging research: 2 observational studies in people.

Disease

2 papers study it4 findings

See all 2 papers on first cardiovascular-kidney-metabolic disease

“During CKMM progression, the HRs for transition from healthy to FCKMD were 1.24 (95% CI: 1.23-1.25) for PhenoAgeAccel”
Biological Age Acceleration and the Dynamic Progression of Cardiovascular-Kidney-Metabolic Diseases to Multimorbidity, Dementia and Mortality: A Prospective Cohort StudyGeriatrics & gerontology international2026doi:10.1111/ggi.70557
  • Humans2

Associations

4

Klemera-Doubal biological age acceleration

upin humans1HR 1.16

1 study
  1. Klemera-Doubal biological age acceleration is linked with a higher risk of first cardiovascular-kidney-metabolic disease in humans during CKMM progression (HR 1.16, 95% CI 1.15-1.17).

    “the HRs for transition from healthy to FCKMD were 1.24 (95% CI: 1.23-1.25) for PhenoAgeAccel and 1.16 (1.15-1.17) for KDM-BA-Accel.”

    Humansduring CKMM progression

    Biological Age Acceleration and the Dynamic Progression of Cardiovascular-Kidney-Metabolic Diseases to Multimorbidity, Dementia and Mortality: A Prospective Cohort Study

    Geriatrics & gerontology international

More on Klemera-Doubal biological age acceleration

PhenoAge

upin humans1HR 1.24

1 study
  1. PhenoAge is linked with a higher risk of first cardiovascular-kidney-metabolic disease in humans during CKMM progression (HR 1.24, 95% CI 1.23-1.25).

    “During CKMM progression, the HRs for transition from healthy to FCKMD were 1.24 (95% CI: 1.23-1.25) for PhenoAgeAccel”

    Humansduring CKMM progression

    Biological Age Acceleration and the Dynamic Progression of Cardiovascular-Kidney-Metabolic Diseases to Multimorbidity, Dementia and Mortality: A Prospective Cohort Study

    Geriatrics & gerontology international

More on PhenoAge

KDM-BA-Accel

upin humans1HR 1.16

1 study
  1. KDM-BA-Accel is associated with first cardiovascular-kidney-metabolic disease in humans (Transition from healthy to first cardiovascular-kidney-metabolic disease) (HR 1.16, 95% CI 1.15–1.17).

    “the hazard ratios (HRs) of the transition from healthy to FCKMD were 1.24 [95%CI 1.23-1.25] for PhenoAgeAccel and 1.16 [1.15-1.17] for KDM-BA-Accel.”

    HumansTransition from healthy to first cardiovascular-kidney-metabolic diseasen = 433,911

    Biological age acceleration and the dynamic progression of cardiovascular-kidney-metabolic diseases to multimorbidity, dementia and mortality: A prospective cohort study

    medRxivPreprint

More on KDM-BA-Accel

PhenoAgeAccel

upin humans1HR 1.24

1 study
  1. PhenoAgeAccel is associated with first cardiovascular-kidney-metabolic disease in humans (Transition from healthy to first cardiovascular-kidney-metabolic disease) (HR 1.24, 95% CI 1.23–1.25).

    “the hazard ratios (HRs) of the transition from healthy to FCKMD were 1.24 [95%CI 1.23-1.25] for PhenoAgeAccel and 1.16 [1.15-1.17] for KDM-BA-Accel.”

    HumansTransition from healthy to first cardiovascular-kidney-metabolic diseasen = 433,911

    Biological age acceleration and the dynamic progression of cardiovascular-kidney-metabolic diseases to multimorbidity, dementia and mortality: A prospective cohort study

    medRxivPreprint

More on PhenoAgeAccel

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 02 papers in 12 months